During the past decade, TREAD Research conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 12 clinical trials were completed, i.e. on average, 63.2% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 8 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "TREAD Research" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Pfizer" with 3 trials sponsored, "Allergan" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Janssen Vaccines & Prevention B.V." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "TREAD Research" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "DACIMA Software" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "TREAD Research" are "COVID-19" (3 trials), "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Gastroparesis" (2 trials) and "Corona Virus Infection" (1 trials). Many other conditions were trialed in "TREAD Research" in a lesser frequency.

Most popular intervention types in "TREAD Research" are "Drug" (17 trials), "Biological" (6 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Empagliflozin" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Acetaminophen/Paracetamol" (1 trials) and "Ad26.COV2.S" (1 trials). Other intervention names were less common.

The vast majority of trials in "TREAD Research" are 23 trials for "All" genders.

Currently, there are NaN active trials in "TREAD Research". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in TREAD Research, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in TREAD Research, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".